Literature DB >> 6292608

U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse.

M F Piercey, R A Lahti, L A Schroeder, F J Einspahr, C Barsuhn.   

Abstract

U-50,488H is a chemically novel analgesic that is a potent opioid-like agent on the mouse tail flick and electrically stimulated guinea pig ileum tests. U-50,488H is a very weak competitor for naloxone binding sites in brain and ileum. However, the drug has high affinity for kappa receptor binding sites revealed by competition for EKC sites in the presence of dihydromorphine. Morphine has both supraspinal and spinal sites of action since it was a potent analgesic after both intracranial and intraspinal injections. However, U-50,488H works predominantly at the spinal level. Dynorphin may be an endogenous ligand at this site. Studies on cat dorsal horn neurons suggest that U-50,488H analgesia may be due to an increase in threshold for neuron excitation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292608     DOI: 10.1016/0024-3205(82)90341-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  Delta-opioid receptors mediate inhibition of fast excitatory postsynaptic potentials in cat parasympathetic colonic ganglia.

Authors:  C Kennedy; J Krier
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

2.  [Met5]enkephalin acts via delta-opioid receptors to inhibit pelvic nerve-evoked contractions of cat distal colon.

Authors:  C Kennedy; J Krier
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

3.  Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.

Authors:  X W Dong; C G Parsons; P M Headley
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

4.  Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor.

Authors:  Zhong Zheng; Xi-Ping Huang; Thomas J Mangano; Rodger Zou; Xin Chen; Saheem A Zaidi; Bryan L Roth; Raymond C Stevens; Vsevolod Katritch
Journal:  J Med Chem       Date:  2017-04-03       Impact factor: 7.446

5.  Opioid modulation of non-cholinergic neural bronchoconstriction in guinea-pig in vivo.

Authors:  M G Belvisi; K F Chung; D M Jackson; P J Barnes
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

6.  Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.

Authors:  H W Matthes; C Smadja; O Valverde; J L Vonesch; A S Foutz; E Boudinot; M Denavit-Saubié; C Severini; L Negri; B P Roques; R Maldonado; B L Kieffer
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

7.  The effects of aging on day-night rhythms of kappa opiate-mediated feeding in the mouse.

Authors:  M Kavaliers; G C Teskey; M Hirst
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.

Authors:  C G Parsons; P M Headley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

9.  Identification of benzomorphan-kappa opiate receptors in cerebral arteries which subserve relaxation.

Authors:  B T Altura; B M Altura; R Quirion
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

10.  Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.

Authors:  A I Faden; T P Jacobs
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.